Vor Ort
Merkzettel Warenkorb
Produktbild: Neuropsychology of Alzheimer's Disease and Other Dementias
Vorbesteller Neu

Neuropsychology of Alzheimer's Disease and Other Dementias

186,99 €

inkl. gesetzl. MwSt., Versandkostenfrei

Beschreibung

Produktdetails

Einband

Gebundene Ausgabe

Erscheinungsdatum

26.08.2026

Herausgeber

Parks Randolph W. + weitere

Verlag

Oxford Academic

Seitenzahl

1256

Maße (L/B)

25,4/17,8 cm

Gewicht

3 g

Auflage

2nd edition

Sprache

Englisch

ISBN

978-0-19-934474-1

Beschreibung

Portrait

Randolph W. Parks, PhD, PsyD, ABN, is an adjunct professor of psychology (ret.) in the Department of Psychology at Southern Illinois University Edwardsville.

Ronald F. Zec, PhD, ABPP-CN, ABN, is an associate professor emeritus in the Department of Neurology at Southern Illinois University School of Medicine and at the Dale and Deborah Smith Center for Alzheimer's Research and Treatment, Neuroscience Institute, Springfield, Illinois.

Mark W. Bondi, PhD, ABPP-CN, is a Distinguished Professor of Psychiatry at the University of California San Diego and director of the Neuropsychological Assessment Unit at the Jennifer Moreno Department of Veterans Affairs Medical Center and University of California San Diego Shirley-Marcos Alzheimer's Disease Research Center.

Angela L. Jefferson, PhD, is a professor in and vice chair of the Department of Neurology, Vanderbilt University School of Medicine, and director of the Vanderbilt Memory and Alzheimer's Center, Nashville, Tennessee.

Produktdetails

Einband

Gebundene Ausgabe

Erscheinungsdatum

26.08.2026

Herausgeber

Verlag

Oxford Academic

Seitenzahl

1256

Maße (L/B)

25,4/17,8 cm

Gewicht

3 g

Auflage

2nd edition

Sprache

Englisch

ISBN

978-0-19-934474-1

Herstelleradresse

Libri GmbH
Europaallee 1
36244 Bad Hersfeld
DE

Email: gpsr@libri.de

Kundinnen und Kunden meinen

0 Bewertungen

Informationen zu Bewertungen

Zur Abgabe einer Bewertung ist eine Anmeldung im Konto notwendig. Die Authentizität der Bewertungen wird von uns nicht überprüft. Wir behalten uns vor, Bewertungstexte, die unseren Richtlinien widersprechen, entsprechend zu kürzen oder zu löschen.

Die Bewertungen sind nach Format, Anzahl Sterne und Datum sortiert.

Verfassen Sie die erste Bewertung zu diesem Artikel

Helfen Sie anderen Kund*innen durch Ihre Meinung

Kundinnen und Kunden meinen

0 Bewertungen filtern
  • Produktbild: Neuropsychology of Alzheimer's Disease and Other Dementias

    • Preface

    • Part I: Introduction to Neuropsychology of Alzheimer's Disease and Aging

    • Chapter 1: Neuropsychology, Neuroanatomy, and Neuropathology of the Anterograde Amnesia of Alzheimer's Disease

    • Ronald F. Zec

    • Chapter 2: Mild Cognitive Impairment and Preclinical Alzheimer's Disease

    • Kelsey R. Thomas, Emily C. Edmonds, Joel S. Eppig, Christina G. Wong, Shanna Cooper, Alexandra J. Weigand, and Mark W. Bondi

    • Chapter 3: Neuropsychology of Normal Aging: The Clinician's Perspective

    • Maura N. Mitrushina

    • Chapter 4: Applications From Cognitive Neuropsychology to the Clinical Assessment of Dementia and Mild Cognitive Impairment

    • Rosie E. Curiel Cid, Arlene Raffo, David Loewenstein, Marcela Kitaigorodsky, and Giselle Leal

    • Chapter 5: Reliability, Validity, and Clinical Decision-Making in Neuropsychological Assessment

    • Otto Pedraza

    • Part II: Differentiating Alzheimer's Disease From Other Cognitive Disorders

    • Neurodegenerative Conditions

    • Chapter 6: Dementia in Lewy Body Diseases and Other Atypical Movement Disorders

    • Denis S. Smirnov, Dawn M. Schiehser, J. Vincent Filoteo, and David P. Salmon

    • Chapter 7: Behavioral Variant Frontotemporal Dementia

    • Megan S. Barker, Jessica Bove, and Katya Rascovsky

    • Chapter 8: Primary Progressive Aphasia

    • Emily Rogalski, Tamar Gefen, and Sandra Weintraub

    • Chapter 9: Vascular Cognitive Impairment

    • Jean K. Ho and Daniel A. Nation

    • Chapter 10: The Dementia of Huntington's Disease

    • Frederick W. Bylsma and Erica K. Sieg

    • Chapter 11: Creutzfeldt-Jakob and Prion Diseases

    • Carlton S. Gass and Ashok Verma

    • Chapter 12: Alzheimer's Disease in Down Syndrome

    • Warren B. Zigman, Nicole Schupf, Sharon J. Krinsky-McHale, and Wayne P. Silverman

    • Medical Neuropsychological Conditions


    • Chapter 13: The Neuropsychology of Multiple Sclerosis

    • Brian M. Sandroff, Joshua Sandry, and John DeLuca

    • Chapter 14: Toxicometabolic Disorders and Nutritional Deficiencies

    • Michael R. Meager, Kathryn V. Lester, and Gregory P. Lee

    • Chapter 15: Communicating Normal Pressure Hydrocephalus

    • Per Hellström, Maria Wallin, Carsten Wikkelsö, and Mats Tullberg

    • Chapter 16: Alcohol-Related Dementia and Wernicke-Korsakoff Syndrome

    • David P. Salmon and William C. Heindel

    • Chapter 17: Neuropsychology Findings in HIV

    • Erin Sundermann, Ni Sun-Suslow, and David J. Moore

    • Chapter 18: Cognition and Cancer

    • Jeffrey S. Wefel and Mariana E. Bradshaw

    • Exposure Conditions

    • Chapter 19: Solvent Encephalopathy and Toxic Exposure

    • Roberta F. White and Caitlin Brand

    • Chapter 20: Traumatic Head Injury and Chronic Traumatic Encephalopathy

    • William B. Barr

    • Part III: Neuropsychiatric Considerations and Co-Morbidities in Dementia

    • Chapter 21: Late-Life Depression, Cognition, and Dementia

    • Rishi Bhalla, Meryl A. Butters, Aaron Koenig, Ruth O'Hara, and Ellen Coman

    • Chapter 22: Cognitive Impairments in Severe Mental Illness in Later Life

    • Philip D. Harvey, Martin T. Strassnig, and Jennifer B. Rosenthal

    • Chapter 23: The Neuropsychiatry of Neurodegenerative Disease

    • Aaron Ritter and Jeffrey L. Cummings

    • Part IV: Dementia Pathophysiology and Brain Imaging

    • Chapter 24: Neuropathological Underpinnings of the Dementias

    • Sonal Agrawal and Julie A. Schneider

    • Chapter 25: Cerebrospinal Fluid Biomarkers in Preclinical and Symptomatic Alzheimer's Disease

    • Doug Galasko

    • Chapter 26: Positron Emission Tomography in Alzheimer's Disease

    • Kacie Deters, Shannon L. Risacher, and Andrew J. Saykin

    • Chapter 27: Structural Neuroimaging Features of Aging and Alzheimer's Disease

    • Patrick J. Lao, Indira C. Turney, and Adam M. Brickman

    • Part V: Risk Factors and Prevention Methods

    • Chapter 28: Risk Factors for Alzheimer's Disease and Dementia

    • Katie E. Osborn, Elizbeth E. Moore, and Angela L. Jefferson

    • Chapter 29: Lifestyle Intervention for Mild Cognition Impairment and Alzheimer's Disease

    • Leslie Vaughan and Laura D. Baker

    • Chapter 30: Pharmacological Interventions for Prevention of Symptomatic Alzheimer's Disease

    • Kathleen A. Welsh-Bohmer, Guy G. Potter, and Brenda L. Plassman

    • Part VI: Pharmacological Intervention, Behavioral Management, and Legal Considerations

    • Chapter 31: Pharmacological Treatment in Alzheimer's Disease

    • Maria Loizos, Judith Neugroschl, and Mary Sano

    • Chapter 32: Adverse Effects of Medications on Cognition in Older Adults

    • Andrea Yevchak-Sillner and Donna Marie Fick

    • Chapter 33: Social Cognition in Dementia

    • Holly Tuokko

    • Chapter 34: Everyday Function in Older Adults

    • Sarah Tomaszewski Farias and Tania Giovannetti

    • Chapter 35: Interventions to Address Functional Decline in Persons With Dementia: Closing the Gap Between What a Person "Does Do" and What They "Can Do"

    • Laura N. Gitlin, Nancy A. Hodgson, Scott Choi, and Katherine Marx

    • Chapter 36: Interventions for the Challenging Behaviors in Dementia

    • Liselotte De Wit and Glenn E. Smith

    • Chapter 37: Medical-Legal Capacities in Mild Cognitive Impairment and Dementia

    • Adam Gerstenecker, Kristen Triebel, and Daniel C. Marson

    • Chapter 38: Selected Legal and Financial Issues in Alzheimer's Disease and Other Dementias

    • Kristen M. Lewis, William H. Overman, and Randolph W. Parks

    • Author Index

    • Test Index

    • Subject Index